Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
NetEase
Watchlist
Tencent/Netease: Netease Tops '23 League Table with Most Games Approved
Equity Bottom-Up
716 Views
25 Dec 2023 04:44
China's game approval process is picking up speed, with more games approved in December. Netease emerged as the leader in game approvals for the year.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Event-Driven
India
Philippines
Equity Derivatives
Asia Event-Driven
Equity Bottom-Up
South Korea
Index Rebalance
Vietnam
Commodities
Trending Insights
More »
The Skew in the Tsuruha-Welcia-Aeon Combination
Betr's "Superior Offer" For PointsBet (PBH AU) Is Questionable
Hanwha Ocean (042660 KS) Placement: Index Implications; Stock Appears Wildly Overvalued
Poon's Underpriced Takeover. Minorities Deserve Better
EA: Easing Stagflationary Noise
Top Unpaywalled Insights
More »
Europe Vs NATO & Trump - U/W Bonds
Overview#24 – Exiting No Man’s Land
[IO Technicals Weekly 2025/17] Bullish Momentum Builds
From Panels to Powerhouses: How Waaree Energies Is Building India’s Solar Backbone
Trade War Winner & Losers - Where To Invest?
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Tencent/Netease: Game Approval Accelerates, but Not for Big Names
26 Jan 2024
Naspers (NPN) X Prosus (PRX) Pairs Trade Opportunity as Naspers Comes Under Pressure
17 Jan 2024
Naspers (NPN) X Prosus (PRX): A Look Back at 2023, Regulatory Risk Back in Spotlight
10 Jan 2024
Tencent/Netease: Netease Tops '23 League Table with Most Games Approved
25 Dec 2023
Tencent/Netease: Game Approval Skewed Towards Netease in '23
12 Dec 2023
Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?
25 Jun 2018
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.1
x